AAEP Member Log in

E-mail:
Password:
Password help
Facebook

AAEP Foundation Asks Veterinarians to Submit Cases for Laminitis Study
First Laminitis Research Project study attempts to identify ris... More »
AAEP Foundation/Markel Insurance Company Honor Top-Achieving Veterinary Students with Scholarships
Eight outstanding equine veterinary students selected for schola... More »
New Jersey Practitioners Selected for 2011 Good Works for Horses Award
The American Association of Equine Practitioners applauds New Je... More »
Convention Attracts 6,400 to San Antonio
The 57th Annual Convention of the American Association of Equine... More »
Florida Practitioner Dr. John Mitchell Leads the AAEP in 2012
New president inducted during the 57th Convention in San Antonio... More »
Reproduction Researcher Dr. Margo Macpherson Begins AAEP Board Service
The American Association of Equine Practitioners welcomed Margo... More »

Vaccine Labeling

Licensed vaccines can afford varying levels of protection. It is important to read and understand product labeling.

Label indications: Data must fully support label indications and accurately reflect the expected performance of the product.

The USDA can grant one of five possible levels-of-protection statements. (Veterinary Services Memorandum No. 800.202; June 14, 2002.) In declining order of level of protection the label claims are:

Prevention of infection:
This claim may be made only for products able to prevent all colonization or replication of the challenge organism in vaccinated and challenged animals.

Prevention of disease:
This claim may be made only for products shown to be highly effective in preventing clinical disease in vaccinated and challenged animals. The entire 95% confidence interval estimate of efficacy must be at least 80%.

Aid in disease prevention:
This claim may be made for products shown to prevent disease in vaccinated and challenged animals by a clinically significant amount which may be less than that required to support a claim of disease prevention (see above).

Aid in disease control:
This claim may be made for products which have been shown to alleviate disease severity, reduce disease duration, or delay disease onset.

Other claims:
Products with beneficial effects other than direct disease control, such as the reduction of pathogen shedding, may make such claims if the size of the effect is clinically significant and well supported by the data.
 
 

© Copyright AAEP 2008